Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
jean tartu
(42 results)?
Public Health Impact and Cost-Effectiveness of Empagliflozin (JARDIANCE®) in the Treatment of Patients with Heart Failure with Preserved Ejection Fraction in France, Based on the EMPEROR-Preserved Clinical Trial.
Pharmacoecon Open. 2024 Jan;8(1):19-30. doi: 10.1007/s41669-023-00432-z. Epub 2023 Aug 22.
Pharmacoecon Open. 2024.
PMID: 37606866
Free PMC article.
Review.
Real-world cost-effectiveness analysis of NOACs versus VKA for stroke prevention in Spain.
Escobar Cervantes C, Martí-Almor J, Cabeza AIP, Bowrin K, Llorac Moix A, Genís Gironès M, Gasche D, Millier A, Tardu J, Toumi M, Briere JB.
Escobar Cervantes C, et al. Among authors: tardu j.
PLoS One. 2022 Apr 20;17(4):e0266658. doi: 10.1371/journal.pone.0266658. eCollection 2022.
PLoS One. 2022.
PMID: 35443000
Free PMC article.
Item in Clipboard
Real-world cost-effectiveness of rivaroxaban and apixaban vs VKA in stroke prevention in non-valvular atrial fibrillation in the UK.
Bowrin K, Briere JB, Levy P, Millier A, Tardu J, Toumi M.
Bowrin K, et al. Among authors: tardu j.
J Mark Access Health Policy. 2020 Jun 25;8(1):1782164. doi: 10.1080/20016689.2020.1782164.
J Mark Access Health Policy. 2020.
PMID: 32944199
Free PMC article.
Item in Clipboard
Cite
Cite